| |
23. |
Advent Partners GPE VII - A Cayman Limited
Partnership, a limited partnership organized under the laws of the
Cayman Islands;
|
| |
24. |
Advent Partners GPE VII - A Limited Partnership, a
Delaware limited partnership;
|
| |
25. |
GPE VII ATI Co-Investment (Delaware) Limited
Partnership (“Advent Co-Invest Fund”), a Delaware limited
partnership;
|
The entities listed in subparagraphs (5) through (10) above
are herein collectively referred to as “Advent Luxembourg Funds.”
The entities listed in subparagraphs (12) through (14) above
are herein collectively referred to as “Advent Cayman Funds.” The
entities listed in subparagraphs (16) through (24) above are
herein collectively referred to as “Advent AP Funds”, and together
with the Advent Luxembourg Funds, the Advent Cayman Funds and
Advent Co-Invest Fund, the
“Advent Funds.”
Wilco GP, an affiliate of Advent, is the General Partner of Wilco
Acquisition. Advent is the manager of Advent Top GP, which in turn
is the General Partner of each of Advent GP Cayman, the Advent AP
Funds, and the Advent Co-Invest Fund. Advent Top GP is also
the manager of Advent GP Luxembourg, which is the General Partner
of each of the Advent Luxembourg Funds. Advent GP Cayman is the
General Partner of each of the Advent Cayman Funds.
The address of the principal business and the principal office of
the Reporting Persons is Prudential Tower, 800 Boylston Street,
Boston, Massachusetts 02199-8069.
The name, business address, present principal occupation or
employment and citizenship of each director and executive officer
(including a director and officer who may be a controlling person)
of Advent is set forth on Schedule A to this Statement.
During the last five years, none of the Reporting Persons or, to
the knowledge of the Reporting Persons, any of the persons listed
on Schedule A attached hereto have been convicted in a criminal
proceeding (excluding traffic violations or similar misdemeanors)
or been a party to a civil proceeding of a judicial or
administrative body of competent jurisdiction and as a result of
such proceeding was or is subject to a judgment, decree or final
order enjoining future violations of, or prohibiting or mandating
activities subject to, federal or state securities laws or finding
any violation with respect to such laws. A joint filing agreement
among the Reporting Persons is attached as Exhibit 1 to this
Statement and incorporated herein by reference.
| Item 4. |
Purpose of Transaction
|
Item 4 of the Schedule 13D is supplemented as follows:
On November 24, 2021, Wilco Acquisition distributed
127,468,397 shares of Common Stock, pro rata and in-kind to its partners, for no
consideration (the “Distribution”). In connection with the
Distribution, the Advent Funds received the shares set forth in
Item 5 below.
| Item 5. |
Interest in Securities of the Issuer
|
Item 5 of the Schedule 13D is supplemented as follows:
The information set forth or incorporated by reference in Items 2
and 6 of this Statement is incorporated by reference in this Item
5.
(a) and (b) The responses of the Reporting Persons to rows
(7) through (13) of the cover pages of this Schedule 13D, as
of November 24, 2021, are incorporated herein by reference. As
of November 24, 2021, the Reporting Persons beneficially owned
in the aggregate 118,662,259 shares of Common Stock, which
represents approximately 57.2% of the outstanding shares.
